The US Food and Drug Administration focused on acute care products in drawing up a list of essential medicines and medical countermeasures for the federal government to procure domestically as a way of preventing critical shortages should the country be cut off from foreign suppliers.
In compiling the initial 30 October list, which the White House gave the FDA just 90 days to produce, the agency chose to leave out medicines for non-acute
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?